Rapid Psychosocial Screening Instruments for Cancer Patients: A Scoping Review of Measurement Tools and Psychometric Evidence
- 1Faculty of Nursing, Universitas Padjadjaran, Sumedang, Jawa Barat, Indonesia.
Abstract
Purpose:: This study aimed to map and synthesize available screening instruments for detecting psychosocial problems in cancer patients.
Methods:: A scoping review was conducted following Arksey and O’Malley’s framework. Literature searches were performed in PubMed, Scopus, and ScienceDirect using predefined keywords, focusing on English-language, full-text, and quantitative studies. Data extraction included study characteristics (title, author, year, objectives, design, sample) and key findings on the validation and application of screening tools. A thematic analysis was performed by two independent reviewers, with discrepancies resolved through discussion, to compare psychometric properties, clinical feasibility, and the scope of detection across instruments.
Results:: Of 18,225 records identified 11 studies met the inclusion criteria. Fourteen screening instruments were identified, including the DT, HADS, PHQ-2, PHQ-9, GAD-7, ESAS, PROMIS Depression Short Form, MAX-PC, DADDS, STAI-S, PHQ-ADS, MADRS-S, e-VAS, and DART. The analysis generated three major themes: (1) psychometric strength (validity and reliability), (2) clinical feasibility (time efficiency, ease of use, applicability across cancer populations), and (3) scope of detection (range of psychosocial problems identified, such as depression, anxiety, general distress, and death anxiety).
Conclusion:: Several rapid screening instruments demonstrate strong psychometric properties and clinical applicability for detecting psychosocial problems in cancer patients. Future research should focus on integrating the most effective tools into oncology practice and on developing a rapid, comprehensive instrument tailored to clinical needs, thereby enhancing early detection and psychosocial care.
Related
- Cross-cultural adaptation and comparative psychometric evaluation of four patient-reported outcome measures for breast cancer-related lymphedema: measurement properties and clinical discrimination
- Psychometric Evaluation of a Transdiagnostic Child and Youth Mental Health Screening Tool in a Canadian Sample: The BCFPI-V3
- A Bayesian Psychometric Item-Level Resource for Korean Early Vocabulary and Developmental Measurement
- A brief measure of life satisfaction: psychometric properties and measurement invariance of the Polish three-item Satisfaction with Life Scale (SWLS-3).
- Psychometric properties and longitudinal measurement invariance of the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale in the Chinese colorectal cancer chemotherapy population.
BibTeX
@article{maryati2026rapid,
title = {{Rapid Psychosocial Screening Instruments for Cancer Patients: A Scoping Review of Measurement Tools and Psychometric Evidence}},
author = {Ida Maryati and Raini Diah Susanti and Taty Hernawaty and Suryani Suryani and Adinda Yulia Maharani and Fillah Azzahra Syafaat and Nissa Fauziyah Sundari and Tetalia Salwa Aisyah},
journal = {Asian Pacific Journal of Cancer Prevention : APJCP},
year = {2026},
month = jun,
doi = {10.31557/apjcp.2026.27.6.1985},
url = {https://doi.org/10.31557/apjcp.2026.27.6.1985},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Rapid Psychosocial Screening Instruments for Cancer Patients: A Scoping Review of Measurement Tools and Psychometric Evidence
AU - Ida Maryati
AU - Raini Diah Susanti
AU - Taty Hernawaty
AU - Suryani Suryani
AU - Adinda Yulia Maharani
AU - Fillah Azzahra Syafaat
AU - Nissa Fauziyah Sundari
AU - Tetalia Salwa Aisyah
PY - 2026
DA - 2026/06/22
JO - Asian Pacific Journal of Cancer Prevention : APJCP
DO - 10.31557/apjcp.2026.27.6.1985
UR - https://doi.org/10.31557/apjcp.2026.27.6.1985
AB - Purpose:: This study aimed to map and synthesize available screening instruments for detecting psychosocial problems in cancer patients. Methods:: A scoping review was conducted following Arksey and O’Malley’s framework. Literature searches were performed in PubMed, Scopus, and ScienceDirect using predefined keywords, focusing on English-language, full-text, and quantitative studies. Data extraction included study characteristics (title, author, year, objectives, design, sample) and key findings on the validation and application of screening tools. A thematic analysis was performed by two independent reviewers, with discrepancies resolved through discussion, to compare psychometric properties, clinical feasibility, and the scope of detection across instruments. Results:: Of 18,225 records identified 11 studies met the inclusion criteria. Fourteen screening instruments were identified, including the DT, HADS, PHQ-2, PHQ-9, GAD-7, ESAS, PROMIS Depression Short Form, MAX-PC, DADDS, STAI-S, PHQ-ADS, MADRS-S, e-VAS, and DART. The analysis generated three major themes: (1) psychometric strength (validity and reliability), (2) clinical feasibility (time efficiency, ease of use, applicability across cancer populations), and (3) scope of detection (range of psychosocial problems identified, such as depression, anxiety, general distress, and death anxiety). Conclusion:: Several rapid screening instruments demonstrate strong psychometric properties and clinical applicability for detecting psychosocial problems in cancer patients. Future research should focus on integrating the most effective tools into oncology practice and on developing a rapid, comprehensive instrument tailored to clinical needs, thereby enhancing early detection and psychosocial care.
SN - 1513-7368
SN - 2476-762X
ER -